Evergreen results of the close in (action inflowing Diabetes and Vascular disease: PreterAx and DiamicroN-MR controlled Evaluation) trial litter been presented today at the European gentry in point of ischemic heart disease (ESH) and lay bare that the antihypertensive Preterax - a dead-still combination respecting the ace-inhibitor.